Physician profile
John Mershon
NPI 1053946947
$744.06
in general payments reported to CMS, 2019-2025
9 companies · $613 in 2025
The $613 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.24 · 2024: $115 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $356.67 | 2024-2025 | Ams 700, General - Kidney Stone Disease, Lumenis Pulse 120h |
| Photocure INC | $110.51 | 2024-2025 | Cysview |
| Janssen Biotech, INC. | $107.32 | 2025 | Carvykti, Rybrevant |
| Avita Medical Americas, LLC | $45.37 | 2025 | Recell, Cohealyx, Permeaderm |
| Coloplast Corp | $38.39 | 2025 | |
| Sumitomo Pharma America, INC. | $32.40 | 2025 | Gemtesa |
| Endo USA, INC. | $21.88 | 2024 | Xiaflex |
| Endo Pharmaceuticals INC. | $16.24 | 2023 | Xiaflex |
| Abc Home Medical Supply, INC. | $15.28 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mershon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.